Clinical Trials · NCT07199894
Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Mansoura University
- Enrollment
- 120
- Start date
- Dec 2024
- Locations
- 1 site, Egypt
- Primary endpoint
- Percentage of improvement in number of wet nights per week